Clinical Trials for ImCheck Therapeutics

Explore 2 clinical trials worldwide

Showing 1-2 of 2 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: ImCheck Therapeutics

Clinical Trials (2)

Phase 1/2a Study of ICT01 Plus Low Dose SC IL-2 in Patients With Advanced Solid Tumors

PHASE1/PHASE2Active, not recruiting

56 participants

Started: Apr 19, 2022 · Completed: Dec 31, 2025

1 condition3 sponsors5 locations

First-in-Human Study of ICT01 in Patients With Advanced Cancer

PHASE1/PHASE2Active, not recruiting

292 participants

Started: Feb 10, 2020 · Completed: Dec 31, 2025

2 conditions1 sponsor29 locations